ABSTRACT. The mechanisms involved in the effect of immune globulin intravenous (IGIV) on bacterial opsonization by both complement pathways in premature serum were elucidated in this study. Of the bacteria used, Staphylococcus aureus and Salmonella enteritidis were nonencapsulated while Streptococcus pyogenes and Escherichia coli 07 K1 were encapsulated. As demonstrated by indirect immunofluorescence, IGIV showed specific antibody titers of 1:32 for S. aureus and S. enteritidis and of 1:8 for S. pyogenes and E. coli 07 K1. IGIV alone had no direct opsonic activity against these organisms. Addition of IGIV did not alter the opsonic activity of normal adult serum against these organisms. In contrast, addition of IGIV promoted the opsonic activity of premature serum against the nonencapsulated bacteria to levels matching that in normal adult serum. The IGIV preparation significantly improved the opsonization of bacteria by the classic (from 39 to 68% of that in adult serum) and alternative (from 22 to 97% of that in adult serum) complement pathways in premature serum. IGIV also markedly augmented C3 deposition on the bacteria by both complement pathways. These studies suggest that IGIV containing high titers of specific antibodies promote opsonization of bacteria by the enhancement of complement pathway activation, especially the alternative pathway, in premature serum. (Pediatr 
Opsonophagocytosis is one of the most important host defense mechanisms against bacterial infection. Optimal opsonophagocytosis of bacteria depends on the presence of both heat-stable (antibodies) and heat-labile (complement) opsonins (1) . Severe and recurrent bacterial infections commonly occur in patients with humoral immunodeficiency. In patients with hypogammaglobulinemia, the use of IGIV has been shown to be effective in preventing bacterial infection (2) (3) (4) .
A defect in opsonic defense to bacteria has been well documented in premature neonates (5) . This deficiency is attributable to lack of effective antibodies and low complement activity (5) . Recently, a number of investigators have suggested that IGIV is beneficial in the prevention or treatment of sepsis in premature and low birth wt neonates (6) (7) (8) . Although IGIV contains antibodies direct against most of the common bacterial pathogens, complement is often necessary for optimal uptake and killing of bacteria by neutrophils (9) . The purpose of this study was to determine the effects of IGIV on the opsonophagocytosis of bacteria by both complement pathways in premature infant serum.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Both gram-negative and gram-positive, encapsulated or nonencapsulated bacteria, were used in this study. Staphylococcus aureus (NCTC6571), Salmonella enteritidis (NCTC6676), Streptococcus pyogenes (NCTC8199), and Escherichia coli 07 K1 (E39916) were obtained from Central Public Health Laboratory, London, England. Each strain was preserved in 12% glycerol in small aliquots at -70" C. In studies of phagocytosis, each strain of bacteria was grown at 37" C in Muller-Hinton broth (Difco Laboratory Co., Detroit, MI) with or without 0.02 mCi of [3H]thymidine (sp act:6.7 Ci/mmol; ICN Radiochemical, CA) for 15 h. The organisms were washed and suspended in PBS (pH 7.4) at 2 x lo8 CW/ml as determined by a spectrophotometer at 620 nm wavelength.
Serum preparations. Venous blood from 12 healthy adult volunteers was allowed to clot at room temperature for 0.5 h. After centrifugation, these sera were pooled as normal adult serum and was stored at -70" C in 1-ml aliquots. Premature serum was obtained from the cord blood of 18 healthy premature newborns whose mean gestational age and mean birth wt were 33 wk and 1775 g, respectively. Premature serum was pooled and stored in 1-ml aliquots at -70" C. Heat inactivation to abolish complement activity was carried out at 56" C for 30 min to produce heat-inactivated adult serum and heat-inactivated premature serum. These heat-inactivated sera showed no complement activity when tested in the total hemolytic complement assay described below. Absorption to remove specific antibody was carried out by incubation of 10" CFU of homologous organisms per ml of serum at 4" C for 1 h. The absorbed sera showed little specific antibody response by an indirect immunofluorescence assay detailed below, but preserved essentially normal complement activity. All of these serum preparations were stored at -70" C until use. Zymosan treatment of serum (4 mg/ml at 37" C for 40 min; Sigma Chemical Co., St. Louis, MO) was used to study the CCP activity (10, 1 I). Mg+-EGTA-treated serum (10 mM of MgC12 and EGTA; Sigma) was used to study ACP activity (12) .
Assays of complement activity. CH50 and AP50 were measured in units of complement at the 50% hemolysis level of antibodysensitized sheep erythrocytes and unsensitized rabbit red blood cells, respectively (1 3). Both complement pathway activities were examined for each serum preparation.
Detection of speciJic antibodies and C3 deposition. Specific antibodies against individual strains of bacteria as well as complement deposition on the bacteria were measured by an indirect immunofluorescence assay (14) . Bacteria (2 X lo8 CFU/ml) were preopsonized with different dilutions (%, '14, ..., to ' /z56) of the serum preparations at 37" C for 30 min. Bacteria were opsonized with absorbed serum in the presence or absence of IGIV (5 mg) to study the effect of IGIV on complement deposition. Opsonized bacteria were washed and suspended to 2 x lo8 CFU/ml in PBS. Each ml of preopsonized bacteria was reacted with 100 pl of % diluted fluorescein-conjugated goat anti-human IgG, C3, or IgM antibody (Cappel, Cooper Biomedicals Inc., Malvern, PA) for 15 min at room temperature. The bacterial suspensions were washed three times and resuspended to 1 ml in PBS. The fluorescence of the second antibodies attached to the bacterial surface was quantitatively detected with a fluorimeter (LS-2B filter, PerkinElmer, Beaconsfield, England) set at 485 and 525 nm wavelengths. The results were expressed as arbitrary units (1 5).
Separation of neutrophils. Venous blood from healthy donors was drawn into plastic syringes containing 10 IU/ml of heparin. Dextran (3%, T500; Pharmacia Fine Chemicals, Piscataway, NJ) was added in a ratio of ' /5, and the syringe was incubated nozzle upward at 37" C for 30 min. The upper fraction of leukocyteenriched plasma was then layered onto Ficoll-Paque (Pharmacia) at a ratio of 2: 1 and was centrifuged at 1500 x g for 10 min. The supernatant was discarded and the pellet was washed, while residual erythrocytes were lysed with 0.83% of ammonium chloride. The neutrophils were finally suspended to lo7 cells/ml in HBSS. Using this method the purity and viability of neutrophils were consistently more than 95 and 98%, respectively.
Opsonization of bacteria. Radiolabeled bacteria (2 x 10' CFU) were opsonized at 37" C for 30 min in 100 pl of different serum preparations in the presence or absence of 100 p1 (5 mg) of IGIV (Gamimune N, Cutter Biological, Berkeley, CA). As indicated to study the interaction between IGIV and complement, the opsonization mixture included 1, 5, or 10% (0.5, 2.5, or 5 mg/ml) IGIV in the presence of different concentrations of complement (absorbed adult or premature serum). The final reaction volume was made up in HBSS to a total of 1 ml. After opsonization, the bacteria were washed three times and resuspended at 2 x lo8 organisms per ml in HBSS. For the intracellular killing assay (detailed below), the bacteria were not radiolabed and the preopsonized bacterial suspension was diluted to 2 x lo7 CFU/ml.
Opsonophagocytic assay. A radioisotope phagocytic assay was performed as previously described (16) . A total of 1 ml of the reaction mixture was set up in duplicate microcentrifuges containing 1) 100 p1 of opsonized bacteria (2 x lo8 CFU/ml), 2) 100 p1 of neutrophil suspension (1 x lo7 cells/ml), and 3) HBSS.
The bacteria to neutrophil ratio was 20: 1 in all experiments and the reactions were incubated at 37" C and rotated end over end for 15 min. At the end of the incubation period, extracellular bacteria were washed away by three cycles of differential centrifugation at 160 x g at 4" C for 4 min. The cell pellet was suspended in 4 ml scintillation liquid (Ultraflour, National Diagnostics, NJ) and counted in a Beckman LS 180 1 scintillation counter (Beckman Instruments, Inc., Fullerton, CA). The opsonophagocytic activity was expressed by an opsonophagocytic index (OPI) defined as a percentage of the cell-associated bacteria in relation to the total bacteria added at time zero (OPI = cpm of cellassociated bacterialcpm of total bacteria in the reaction x 100%).
Purification of F ( U~' )~ from IGIV. F(ab')z fragments were purified from pepsin-treated IGIV by a modification of a technique previously described (17) . IGIV was digested with pepsin (Sigma) at the substrate to enzyme ratio of 50/1. The reaction was camed out in 0.1 M acetate buffer, pH 4.2, at 37" C for 16 h. The F(ab')2 fragments were further purified by gel filtration chromatography, using ULTROGEL AcA 44 (Pharmacia) to remove Fc fragments and intact IgG. Fractions containing F(ab')2 were pooled, dialyzed in PBS, and concentrated to 6 mg/ ml. This pool contained no intact IgG or Fc fragments when analyzed by a 5 to 15% gradient SDS-PAGE (Fig. 1) .
Intracellular killing assay. Inasmuch as the radioisotope phagocytic assay we used likely detects both attached and ingested bacteria by neutrophils, we also used an acridine orange/crystal violet microassay to simultaneously differentiate ingestion from attachment as well as intracellular killing. The assay was a modification of previously described procedures (18) (19) (20) . Oneml aliquots of neutrophils (2 x lo6 cells/ml) were pretreated withlwithout 10 pg/ml of anti-CR1 (44D) and/or anti-CR3 (Leu 15) MAb (Becton Dickinson, Inc., Mountain View, CA) at 4" C for 30 min. The MAb, Leu 15, has been well characterized. AntiCRl antibodies produced by clone 44D have also been characterized by a number of investigators (21) (22) (23) . This MAb (44D) is directed against CRl receptors on erythrocytes, polymorpho- nuclear cells, mononuclear cells, and T lymphocytes, and specifically inhibit EAC3b rosette formation (21) . Based on a preliminary study using a flow cytometric technique, this antibody concentration (10 &ml) was the optimal concentration for saturating complement receptors on neutrophils and did not affect neutrophil viability as determined by trypan blue exclusion. After washing, the suspensions were mixed with 1 ml (2 x lo7 CFU/ml) of preopsonized S. aureus. Duplicate samples containing 0.5 ml of the reaction mixture were then put on coverslips (18 x 18 mm2) for 2-h incubation at 37" C. At the end of the incubation, the coverslips were washed and stained with 0.01% of acridine orange (Sigma) for 60 s followed by staining with 0.05% of crystal violet (Sigma) for 50 s. After such staining, viable bacteria emitted green fluorescence while nonviable organisms emitted red fluorescence. Crystal violet, a large molecule that cannot enter neutrophils, quenches the fluorescence of all the bacteria remaining extracellular or membrane-adherent. Thus, the technique allows one to differentiate ingested from uningested or adherent organisms. In addition, the number of the intracellular viable (green) and nonviable (red) bacteria can be determined by the color of the fluorescence they emit. A phagocytic index (PI) was defined as the total number of intracellular bacteria (viable and nonviable) per 100 neutrophils. A bactericidal index (BI) was expressed as the total number of intracellular nonviable (red) bacteria per 100 neutrophils. Intracellular killing (ICK) was calculated from the number of intracellular dead (red) bacteria/total number of intracellular dead (red) and viable (green) bacteria X 100% (ICK = BI/PI x 100%).
RESULTS
Fluorescence measurement of speciJic serum antibodies. Using an immunofluoresence assay to detect the presence of serum antibodies interacting with the surface of the bacteria, we found that as the concentration of normal adult serum or premature serum increased, so did the amount of antibody bound to nonencapsulated S. aureus and S. enteritidis. The antibody titer in premature serum was lower than that of normal adult serum (Fig. 2) 210g serum d~l u t~o n 'log serum d~l u l~o n 
Fig. 3. Effects of IGIV on the complement-dependent opsonization of S. aureus. Left, heat-inactivated adult serum (HAS) alone could reconstitute optimal opsonization at 6-10% (v/v) absorbed adult serum (AAS).
Right, a higher concentration of IGIV (5 mg/ml), in addition to heat-inactivated premature serum (HPS), was required to accomplish optimal opsonization at 10% absorbed premature serum (APS). Data are plotted by the means of three duplicate experiments. premature serum (P < 0.01), but did not augment C3 deposition on bacteria in normal adult serum (Fig. 4) .
Effects of F(abt)2 on complement-dependent phagocytosis and intracellular killing.
As demonstrated by the radioisotope assay of phagocytic uptake, IGIV alone had no opsonic activity for these organisms. It did, however, enhance opsonophagocytosis in the presence of complement. Enhancement of opsonophagocytosis by the addition of IGIV may be mediated by complement receptors, Fc receptors, or both mechanisms. We found that F(ab')2 fragments prepared from the IGIV enhanced uptake and killing of S. aureus by neutrophils only in the presence of complement (Table 4 ). This result suggests that F(ab')2 fragments can trigger complement activation and result in phagocytosis through a complement-mediated mechanism. Neutrophils have two types of complement receptors, CRI and CR3, on their surfaces. We blocked CRl and/or CR3 with monoclonal anti- bodies to examine the role of these complement receptors. Blockade of CRI did not affect the opsonophagocytosis of S. aureus; blocking CR3 significantly inhibited both phagocytic and bactericidal indices of the bacteria by neutrophils (Table 4) . Blocking these receptors did not, however, alter intracellular killing (Table  4 ). In addition, complement in combination with intact IgG ( 5 mg/ml) had a higher opsonic activity than did equimolar concentration (3 mg/ml) of F(ab')2 fragments (Table 4) , indicating synergism between complement-and Fc receptor-dependent phagocytosis. * Complement (C') source was 10% absorbed adult serum. B1, bactericidal index; PI, phagocytic index; ICK, intracellular killing. Preopsonization concentrations of F(abO2 and IGIV were 3 and 5 mg/ml, respectively. Data are expressed as mean f SD calculated by three duplicate experiments.
DISCUSSION
Defective opsonization of bacteria by premature serum is due to lack of effective antibodies and low complement activity (5) . In this study, we have demonstrated that the opsonic effects of premature serum on S. aureus and S. enteritidis can be increased by the addition of IGIV. We have also shown that IGIV enhances opsonization and C3 deposition by both complement pathways, especially the alternative pathway, in premature serum.
Activation of the complement system can occur via two pathways, both of which can be modulated by Ig (24) . IGIV alone has little capacity to initiate nonspecific complement activation (25) and low opsonic activity when used alone against most of the common bacterial pathogens (9) . In the presence of complement, IGIV markedly enhanced the opsonic activity against a variety of bacterial pathogens (9) . In this study, we found that a high concentration of IGIV (5 mg/ml) was able to promote the opsonic activity in premature serum to a level matching that in normal adult serum (Fig. 3) . This concentration of IGIV also augmented opsonic activity and C3 deposition on bacteria by both complement pathways in premature serum (Table 3 ; Fig.  4 ). Opsonization of bacteria that are alternative pathway activators is believed to be mediated by an antibody-independent route (26) . Several studies, however, have shown that antibodies can also activate the alternative complement pathway (27-3 1) . Nydegger and Kazatchkine (32) , composing a schematic representation of the interaction between immune complexes and complement, have proposed that C3b is able to bind to the F(ab'l2 portion of antibody and trigger alternative pathway activation. In this study, we have also demonstrated that F(ab')2 fragments of IGIV enhance phagocytosis of S. aureus only in the presence of complement. This F(ab')z-enhanced phagocytosis can be largely blocked by MAb to complement receptors. These data further support the concept that F(abf)2 fragments of IgG enhance complement deposition and phagocytosis through activation of the alternative pathway. Intact IgG, in the presence of complement, caused more phagocytosis than did equimolar amount of F(~ib')~ ( Table 4 ), indicating that Fc-mediated mechanisms, either activation of complement, or interaction with Fc receptor, are required for most efficient opsonophagocytosis.
Employing an AO/CV microassay that allows one to simultaneously assess actual ingestion as well as intracellular killing, we observed that F(ab')2 fragments purified from the IGIV preparation elicited complement-mediated phagocytosis. We also demonstrated that CR3, but not CR1, was the major receptor for complement-mediated phagocytosis of S. aureus by neutrophils. These results are similar to those of Anderson et al. (33) that indicated phagocytic killing of S. aureus by neutrophils was significantly inhibited by anti-CR3 but not anti-CRl MAb. In addition, we found that blockade of CR1 and/or CR3 had no effect on intracellular killing of the organism by neutrophils.
As demonstrated by the quantitative immunofluoresence assay, specific IgG antibody titers against nonencapsulated bacteria in IGIV, premature serum, and normal adult serum were higher than those against encapsulated bacteria. In contrast, specific IgM antibodies against these organisms were not detectable in premature serum. In normal adult serum, there was a low IgM titer (1:2) for the nonencapsulated organisms but undetectable levels of IgM against the encapsulated strains of bacteria. IGIV enhanced the opsonic activity of premature serum against the nonencapsulated bacteria in the presence of complement (absorbed serum), but not that for the encapsulated bacteria ( Table  2 ). Using human IgM purified from normal adult serum, we found that the IgM preparation did not promote opsonophagocytosis of these encapsulated and nonencapsulated bacteria in the presence of complement (data not shown). These studies suggested that optimal opsonization for these nonencapsulated bacteria was predominantly IgG-dependent. Poor opsonization for the encapsulated bacteria might be due to the lack of effective specific IgM antibody against the organisms in premature serum, normal adult serum, and the IGIV preparation. Not surprisingly, premature serum had undetectable specific IgM antibodies to these organisms because premature B cells have a limited ability to produce IgM antibody. The fact that normal adult serum had low or absent specific IgM antibodies against these organisms suggests that the donors had not been recently exposed to these organisms. Capsular polysaccharride often results in a primary immune response of the IgM class and little or no immunologic memory (26) . Another possibility is that capsular antigen, such as the K antigen of E. coli, may inhibit complement activation and phagocytosis (34) .
Although the IGIV preparation contained higher specific IgG antibodies against certain bacteria such as S. aureus and S. enteritidis (Fig. 2) , these antibodies were not opsonic by themselves. As shown in Table 2 , IGIV either alone or in combination with heat-inactivated adult or premature serum demonstrated no opsonic activities for the organisms. In contrast, IGIV or F(ab')2 fragments purified from the IGIV preparation promoted opsonophagocytosis in the presence of complement. These data suggest that antibodies in the IGIV result in the activation of complement and the promotion of complement dependent phagocytosis. This is in agreement with the studies of Hill et al. (9) that showed IGIV alone had virtually no opsonic activity for most of the common bacterial pathogens. Furthermore, these authors found that the enhancement of bacterial opsonization by IGIV was correlated with the ability to consume complement by the IGIV-opsonized bacteria (23) . This study, therefore, indicates that supplementation of premature serum with an IGIV preparation containing higher titers of specific antibody enhances the opsonophagocytosis of bacteria primarily through an amplification of complement activation, especially the alternative pathway. This feature must be considered during the development of therapeutic regimens for the prevention and prophylaxis of sepsis with passive immunotherapy in the premature.
